A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15–070) in combination with docetaxel in patients with relapsed non-small cell lung cancer (NSCLC)
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. B. Haura, C. A. Williams, A. A. Chiappori, J. Adams, D. W. Northfelt, S. M. Malik, D. Van Echo, M. J. Edelman, M. Berger
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2255307237